CLINICAL_TRIALS
trial_result
· 2019-08-06
Clinical Trial Update: An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation [Phase 4]
Summary
Phase 4 imaging study investigating the effect of intravenous reslizumab on airway inflammation in asthma; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 4 | Status: TERMINATED | Results posted: 2019-08-06